Skip to content

Waratek

Compiler-based RASP and IAST platform that virtually patches Java applications at the JVM level, including legacy runtimes, without requiring immediate code changes.

Visit Website ↗ + Add to Compare
45/100Emerging / Unranked

Overview

Waratek builds a compiler-based runtime protection platform for Java applications, combining Runtime Application Self-Protection (RASP) and Interactive Application Security Testing (IAST) into a single agent that instruments the Java Virtual Machine itself rather than the network traffic around it. Because the technology works at the JVM/bytecode level, Waratek can virtually patch known vulnerabilities (including in legacy, unsupported Java runtimes) and block exploitation of flaws like deserialization attacks or injection without requiring immediate code changes or emergency patching windows.

The company won the RSA Conference Innovation Sandbox in 2015 for this approach, at a time when RASP was still an emerging category distinct from perimeter-based WAF tooling. Waratek has stayed narrowly focused on Java (and, more recently, AI-generated code) rather than expanding into a broad multi-language platform, which keeps its footprint small relative to larger application security vendors but has let it remain a specialist option for large enterprises still running substantial legacy Java estates.

Waratek is a small, independently operated company that has not raised new outside capital since its early funding from Mangrove Capital Partners, and it competes in a RASP/IAST market that has consolidated significantly as larger platform vendors folded similar capability into broader application security suites. Its continued relevance rests on the depth of its Java-specific virtual patching rather than category-wide breadth.

Innovation Matrix Assessment

Innovation Velocity 4/10

Waratek has not disclosed a new funding round or major architectural release in recent years; public activity is largely marketing content and incremental product updates rather than evidence of fast iteration.

Operational Value 6/10

The compiler-level JVM instrumentation approach lets Waratek virtually patch known Java vulnerabilities and block exploit patterns without code changes, which is operationally useful for enterprises with large legacy Java estates that cannot patch quickly.

Market Momentum 3/10

No new funding rounds, acquisitions, or significant customer announcements have surfaced since its early-2010s raises; the company appears to be operating at steady state rather than growing market share.

Category Disruption 4/10

Waratek was an early mover in RASP/IAST and won the RSA Innovation Sandbox in 2015, but the category has since been absorbed into broader application security suites from larger vendors, reducing the disruptive edge of a standalone point solution.

Real-World Efficacy 5/10

The virtual patching approach is technically sound and long-established, but there is no recent independent third-party testing or named enterprise case study available publicly to verify current real-world efficacy at scale.

Enduring Relevance 5/10

Legacy Java applications remain common in large enterprises (banking, government, insurance), keeping JVM-level virtual patching relevant, though the addressable market is narrower than multi-language application security platforms.

Why CISOs Should Care

Gives security teams a way to virtually patch known Java vulnerabilities and block exploitation in legacy or unsupported JVM environments without waiting for a code release cycle.

What Makes It Different

Operates at the compiler/JVM bytecode level rather than instrumenting network traffic or source code, letting it protect even unsupported legacy Java runtimes that other RASP tools cannot reach.

The Matrix Verdict

45/100 — EMERGING / UNRANKED

A credible, technically differentiated niche player for Java-specific runtime protection, but its lack of recent funding, disclosed customers, or independent validation limits confidence in its current market traction.

Editorial Note: Claims vs. Verified Findings

The RSA Innovation Sandbox win (2015) and Mangrove Capital funding are independently verifiable. Employee counts and any performance/detection-rate claims come from vendor and data-aggregator sources and were not independently confirmed with named customers.

Sources